70 Participants Needed

Home Blood Pressure Monitoring for Liver Cirrhosis

(WATCH Trial)

GC
HC
Overseen ByHannah Chao
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Francisco
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a randomized single-blind feasibility trial to test the utilization of home blood pressure devices to improve the clinical management of decompensated cirrhosis patients.

Who Is on the Research Team?

GC

Giuseppe Cullaro, MD, MAS

Principal Investigator

University of California, San Francisco

Are You a Good Fit for This Trial?

This trial is for patients with advanced liver cirrhosis (Child Pugh Score ≥ 7), which means their liver is severely scarred and not working well. The study aims to help manage their condition using home blood pressure monitoring.

Inclusion Criteria

My liver disease is severe, with a Child Pugh Score of 7 or higher.

Exclusion Criteria

N/A

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use home blood pressure monitors and scales to inform clinical decisions

24 weeks
Weekly data review

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Withings Home Blood Pressure Device and Scale
Trial Overview The trial is testing if using a Withings Home Blood Pressure Device and Scale can improve the treatment of decompensated cirrhosis compared to standard care alone. It's a randomized single-blind study, meaning some patients will use the device while others won't, and they won't know which group they're in.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Home Blood Pressure and Scale Monitoring to Inform Clinical DecisionsExperimental Treatment1 Intervention
This arm will receive a home blood pressure monitor and scale. These data will be reviewed weekly and these data will be shared with the treating provider to inform clinical decisions.
Group II: Standard of CarePlacebo Group1 Intervention
This arm will receive a home blood pressure monitor and scale; however, these data will not be shared with their treating provider in real-time.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security